Bioneer looks forward to the symposium held at Cancer Research UK Institute in Cambridge, which brings together different in situhybridization (ISH) technology users from academia, hospitals and industry.
At the event established, updated as well as brand new ISH applications will be presented and discussed. Come and take part of how you can use this tool for scientific discoveries and clinical diagnosis.
Dr. Schnack-Nielsen will present during the program’s first session on ‘Insights to Multiplexing Challenges’.
Boye Schnack-Nielsen, heading the molecular histology activities at Bioneer, is one of seven members constituting the Scientific Organising Committee for the symposium. He has vast experience of different in situ hybridization and immunohistochemistry technologies, and is pushing the limits for multiplexing combinations of microRNA, RNA, DNA and proteins.